1
|
Lillo E, Gutierrez-Cardo A, Murcia-Casas B, Carrillo-Linares JL, Garcia-Argüello F, Chicharo de Freitas R, Baquero-Aranda I, Valdivielso P, García-Fernández M, Sánchez-Chaparro MÁ. Cutaneous and Vascular Deposits of 18F-NaF by PET/CT in the Follow-Up of Patients with Pseudoxanthoma Elasticum. J Clin Med 2021; 10:jcm10122588. [PMID: 34208205 PMCID: PMC8230828 DOI: 10.3390/jcm10122588] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Revised: 06/02/2021] [Accepted: 06/08/2021] [Indexed: 12/19/2022] Open
Abstract
Active microcalcification of elastic fibers is a hallmark of pseudoxanthoma elasticum and it can be measured with the assessment of deposition of 18F-NaF using a PET/CT scan at the skin and vascular levels. It is not known whether this deposition changes over time in absence of specific therapy. We repeated in two years a PET/CT scan using 18F-NaF as a radiopharmaceutical in patients with the disease and compared the deposition at skin and vessel. Furthermore, calcium score values at the vessel wall were also assessed. Main results indicate in the vessel walls that calcification progressed in each patient; by contrast, the active microcalcification, measured and target-to-background ratio showed reduced active deposition. By contrast, at skin levels (neck and axillae) the uptake of the pharmaceutical remains unchanged. In conclusion, because calcification in the arterial wall is not specific for pseudoxanthoma elasticum condition, the measurement of the deposition of 18F-NaF in the neck might be potentially used as a surrogate marker in future trials for the disease.
Collapse
Affiliation(s)
- Eugenia Lillo
- Molecular Imaging Unit, Centro de Investigaciones Médico Sanitarias (CIMES), Fundación General de la Universidad de Málaga, 29010 Málaga, Spain; (E.L.); (R.C.d.F.)
| | - Antonio Gutierrez-Cardo
- Nuclear Medicine Department, Regional Hospital, 29010 Malaga, Spain;
- Biomedical Research Institute of Malaga (IBIMA), 29010 Malaga, Spain; (J.L.C.-L.); (F.G.-A.); (M.G.-F.); (M.Á.S.-C.)
| | - Belén Murcia-Casas
- Internal Medicine Unit, Virgen de la Victoria Hospital, 29010 Malaga, Spain;
| | - Juan Luis Carrillo-Linares
- Biomedical Research Institute of Malaga (IBIMA), 29010 Malaga, Spain; (J.L.C.-L.); (F.G.-A.); (M.G.-F.); (M.Á.S.-C.)
- Internal Medicine Unit, Virgen de la Victoria Hospital, 29010 Malaga, Spain;
| | - Francisco Garcia-Argüello
- Molecular Imaging Unit, Centro de Investigaciones Médico Sanitarias (CIMES), Fundación General de la Universidad de Málaga, 29010 Málaga, Spain; (E.L.); (R.C.d.F.)
- Biomedical Research Institute of Malaga (IBIMA), 29010 Malaga, Spain; (J.L.C.-L.); (F.G.-A.); (M.G.-F.); (M.Á.S.-C.)
| | - Reinaldo Chicharo de Freitas
- Molecular Imaging Unit, Centro de Investigaciones Médico Sanitarias (CIMES), Fundación General de la Universidad de Málaga, 29010 Málaga, Spain; (E.L.); (R.C.d.F.)
| | | | - Pedro Valdivielso
- Biomedical Research Institute of Malaga (IBIMA), 29010 Malaga, Spain; (J.L.C.-L.); (F.G.-A.); (M.G.-F.); (M.Á.S.-C.)
- Internal Medicine Unit, Virgen de la Victoria Hospital, 29010 Malaga, Spain;
- Department of Medicine and Dermatology, University of Malaga, 29010 Malaga, Spain
- Correspondence: ; Tel.: +34-952131615; Fax: +34-952131511
| | - María García-Fernández
- Biomedical Research Institute of Malaga (IBIMA), 29010 Malaga, Spain; (J.L.C.-L.); (F.G.-A.); (M.G.-F.); (M.Á.S.-C.)
- Department of Human Physiology, University of Malaga, 29010 Malaga, Spain
| | - Miguel Ángel Sánchez-Chaparro
- Biomedical Research Institute of Malaga (IBIMA), 29010 Malaga, Spain; (J.L.C.-L.); (F.G.-A.); (M.G.-F.); (M.Á.S.-C.)
- Internal Medicine Unit, Virgen de la Victoria Hospital, 29010 Malaga, Spain;
- Department of Medicine and Dermatology, University of Malaga, 29010 Malaga, Spain
| |
Collapse
|
2
|
Sciorsci RL, Lillo E, Occhiogrosso L, Rizzo A. Ozone therapy in veterinary medicine: A review. Res Vet Sci 2020; 130:240-246. [PMID: 32234614 DOI: 10.1016/j.rvsc.2020.03.026] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2020] [Revised: 03/18/2020] [Accepted: 03/25/2020] [Indexed: 10/24/2022]
Abstract
Ozone (O3) is a triatomic form of oxygen. As O3 rapidly dissociates into water and releases a reactive form of oxygen that may oxidize cells, the gas mixture of O3/O2 is used in medicine. ATP is widely available for cellular activity. O3 can be administered via the systemic and local routes. Although O3 is known as one of the most powerful oxidants, it also promotes antioxidant enzymes. Additionally, it stimulates some of the cells of the immune system and inactivates pathogens, including bacteria, fungi, yeasts, protozoa, and viruses. Owing to these activities, O3 is used to improve several diseases, both in human and in veterinary medicine. Considering the wide scope of O3 application, the aim of this review was to reiterate the mechanisms of action of O3 and its utilization in different mammalian species (bovine, ovine-caprine, equine, canine, porcine).
Collapse
Affiliation(s)
- R L Sciorsci
- Department of Veterinary Medicine, University of Bari Aldo Moro, S.P. per Casamassima km. 3, 70010 Valenzano, BA, Italy.
| | - E Lillo
- Department of Veterinary Medicine, University of Bari Aldo Moro, S.P. per Casamassima km. 3, 70010 Valenzano, BA, Italy
| | - L Occhiogrosso
- Department of Veterinary Medicine, University of Bari Aldo Moro, S.P. per Casamassima km. 3, 70010 Valenzano, BA, Italy
| | - A Rizzo
- Department of Veterinary Medicine, University of Bari Aldo Moro, S.P. per Casamassima km. 3, 70010 Valenzano, BA, Italy
| |
Collapse
|
3
|
Villena García AC, Cardo AG, Hidalgo CM, Palomo L, Lillo E, Espíldora J, Trigo JM, Chaparro MÁS, Valdivielso P. 18FDG PET/CT & arterial inflammation: predicting cardiovascular events in lung cancer. QJM 2019; 112:401-407. [PMID: 30715503 DOI: 10.1093/qjmed/hcz036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/12/2018] [Revised: 01/25/2019] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND 18F-FDG PET/CT predicts cardiovascular disease. To analyze the predictive value of cardiovascular events from inflammation and arterial calcification in patients who underwent an 18F-FDG PET/CT for lung cancer. METHODS A retrospective study of 274 patients with primary lung neoplasia. We determined: (i) TBR (target-to-background ratio), and (ii) the calcium score, at eight common arterial segments. We took as arteriosclerosis, a TBR ≥1.6 and ≥15 Calcium Score sum. We registered cardiovascular risk factors, comorbidities, histology, stage, treatment, status at the last clinical review, cause of death and cardiovascular event during the follow-up. RESULTS The territory presenting the greatest uptake of 18F-FDG, was the thoracic aorta with an average of 1.77 (± 0.27 TBR) in the aortic arch, while the greatest degree of calcification was obtained in the abdominal aorta (52% with a Calcium Score ≥ 3). 24% of the patients presented a sum Calcium Score ≥15, and 17% a TBR ≥1.6. Patients with high TBR, (17%), had not a higher frequency of cardiovascular comorbidities beforehand, nor did they in the follow-up. However, those with a sum Calcium Score ≥15 (24%), were older, had more cardiovascular risk factors and ischemic events during follow-up. The calcium score, but not the TBR, predicted the emergence of a cardiovascular event (HR 4.9 IC95% 2.1-9.1, P < 0.05). CONCLUSION In our cohort, a high Calcium Score was an independent predictor for developing cardiovascular events.
Collapse
Affiliation(s)
- A C Villena García
- Nuclear Medicine, Molecular imaging department, Centro de Investigaciones Médico Sanitarias (CIMES)
| | - A Gutierrez Cardo
- Nuclear Medicine, Molecular imaging department, Centro de Investigaciones Médico Sanitarias (CIMES)
| | - C M Hidalgo
- Department of Medicine and Dermatology, University of Malaga, Málaga, Spain
| | - L Palomo
- Department of Medicine and Dermatology, University of Malaga, Málaga, Spain
| | - E Lillo
- Nuclear Medicine, Molecular imaging department, Centro de Investigaciones Médico Sanitarias (CIMES)
| | | | - J Manuel Trigo
- Oncology, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain
| | - M Á Sánchez Chaparro
- Internal Medicine, Hospital Clínico Universitario Virgen de la Victoria, Department of Medicine and Dermatology, Insituto de Investigaciones Biomédicas de Málaga (IBIMA), University of Malaga, Málaga, Spain
| | - P Valdivielso
- Internal Medicine, Hospital Clínico Universitario Virgen de la Victoria, Department of Medicine and Dermatology, Insituto de Investigaciones Biomédicas de Málaga (IBIMA), University of Malaga, Málaga, Spain
| |
Collapse
|
4
|
Mégevand JL, Lillo E, Amboldi M, Lenisa L, Ambrosi A, Rusconi A. TME for rectal cancer: consecutive 70 patients treated with laparoscopic and robotic technique-cumulative experience in a single centre. Updates Surg 2019; 71:331-338. [PMID: 31028665 DOI: 10.1007/s13304-019-00655-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2018] [Accepted: 04/02/2019] [Indexed: 02/07/2023]
Abstract
From January 2011 to December 2015, 70 consecutive patients underwent either laparoscopic surgery (LS) or robotic surgery (RS) total mesorectal excision (TME) for malignancy. Data were prospectically recorded in a dedicated local database including ASA score, age, operative time, conversion rate, re-operation rate, early complications, length of stay, and pathological results. We enrolled 70 consecutive patients, 35 treated with LS (18 M, 17 F), 35 treated with RS (23 M, 12 F). Median total operative time was 225 min in LS group (IQR 194-255) and 252.5 min for RS group (IQR 214-300). Median first flatus time was 2 days for LS group (IQR 1-3) and 1 day for RS group (IQR 1-2). Stool discharge time (median) was 4 days for LS group (IQR 2-5) and 2 days for RS group (IQR 1-3). Length of stay (median) was 8 days in LS group (IQR 7-10) and 7 days in RS group (IQR 5-8). It was not found any statistically significant difference between the two groups when we analyzed the number nodes harvested the postoperative complications. The 30 day mortality was 0% in both two groups. The conversion rate for LS group was 23% (8/35 pts) and that for RS group was 0% (0/35). The RS may overcome technical limitations of LS. In our experience, it is a feasible and safe technique, it achieves better clinical outcomes due to the lower conversion rate compared to LS, although with higher costs.
Collapse
Affiliation(s)
- J L Mégevand
- Division of General Surgery, Department of Surgery, Humanitas S. Pio X Hospital, Via Nava 31, 20159, Milan, IT, Italy.
| | - E Lillo
- Division of General Surgery, Department of Surgery, Humanitas S. Pio X Hospital, Via Nava 31, 20159, Milan, IT, Italy
| | - M Amboldi
- Division of General Surgery, Department of Surgery, Humanitas S. Pio X Hospital, Via Nava 31, 20159, Milan, IT, Italy
| | - L Lenisa
- Division of General Surgery, Department of Surgery, Humanitas S. Pio X Hospital, Via Nava 31, 20159, Milan, IT, Italy
| | - A Ambrosi
- Vita-Salute San Raffaele University, 20132, Milan, Italy
| | - A Rusconi
- Division of General Surgery, Department of Surgery, Humanitas S. Pio X Hospital, Via Nava 31, 20159, Milan, IT, Italy
| |
Collapse
|
5
|
Mégevand JL, Amboldi M, Lillo E, Lenisa L, Ganio E, Ambrosi A, Rusconi A. Right colectomy: consecutive 100 patients treated with laparoscopic and robotic technique for malignancy. Cumulative experience in a single centre. Updates Surg 2018; 71:151-156. [PMID: 30448923 DOI: 10.1007/s13304-018-0599-0] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2018] [Accepted: 10/08/2018] [Indexed: 12/11/2022]
Abstract
Robotic-assisted resections prove beneficial in overcoming potential limitation of laparoscopy, but clear evidences on patient's benefits are still lacking. We report our experience on 100 consecutive patients who underwent right colectomy with either robotic or laparoscopic approaches. Data were prospectively collected on a dedicated database (ASA score, age, operative time, conversion rate, re-operation rate, early complications, length of stay, and pathological results). Median total operative time was 160 min in LS group (IQR = 140-180) and 204 min for RS group (IQR = 180-230). Median time to first flatus was 2.5 days for LS group (IQR = 2 - 3) and 2 days for RS group (IQR = 1-2). Length of stay (median) was 8 days in LS group (IQR = 6-10) and 5 days in RS group (IQR = 5-7). No statistically significant difference was found between the 2 groups when the number of harvested nodes, the anastomotic leakage and the postoperative bleeding were analyzed. The 30-day mortality was 0% in LS and RS groups. Conversion rate for LS group was 14% (7/50 pts) and for RS group was 0% (0/50). Minimally invasive surgery is a feasible and safe technique. The RS may overcome some technical limitations of laparoscopic surgery and it achieves the same oncological results compared to LS but with higher costs. The lower conversion rate allows to expect better clinical outcomes and lower complication rate.
Collapse
Affiliation(s)
- J L Mégevand
- Division of General Surgery, Department of Surgery, Humanitas S. Pio X Hospital, Via Nava 31, 20159, Milan, Italy.
| | - M Amboldi
- Division of General Surgery, Department of Surgery, Humanitas S. Pio X Hospital, Via Nava 31, 20159, Milan, Italy
| | - E Lillo
- Division of General Surgery, Department of Surgery, Humanitas S. Pio X Hospital, Via Nava 31, 20159, Milan, Italy
| | - L Lenisa
- Division of General Surgery, Department of Surgery, Humanitas S. Pio X Hospital, Via Nava 31, 20159, Milan, Italy
| | - E Ganio
- Division of General Surgery, Department of Surgery, Humanitas S. Pio X Hospital, Via Nava 31, 20159, Milan, Italy
| | - A Ambrosi
- Vita-Salute San Raffaele University, 20132, Milan, Italy
| | - A Rusconi
- Division of General Surgery, Department of Surgery, Humanitas S. Pio X Hospital, Via Nava 31, 20159, Milan, Italy
| |
Collapse
|
6
|
Rademacher J, Cansolino L, Crespi S, Lenti LM, Lillo E, Tubazio I, Oldani O, Passalia L, Maestri M, Gaspari A, Dionigi P. [Immunomodulation after combined spleen and kidney transplantation in swine]. MINERVA CHIR 2006; 61:85-94. [PMID: 16871139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
AIM Organ transplantation is the most effective treatment for several degenerative end-stage diseases. While the mainstream immunosuppression can achieve satisfactory results, the therapy has either side effects and flaws. The golden target to reach should be a stable tolerance with the transplanted organ accepted without a long term drug administration. Recent studies demonstrated a tolerogenic effect of spleen cells. Aim of this study is to evaluate a model of combined spleen and whole organ transplantation in a significant preclinical setting in swine. METHODS Twenty-five outbred Landrace/Large-White swine underwent combined spleen/kidney transplantation (SKTx). The experiments were stratified into 3 groups per randomization. Group 1 (N=7) received kidney transplantation (KTx) alone with no immunosuppressive treatment. Group 2 (N=9) had a combined KTx and whole graft spleen Tx. Group 3 (N=9) had KTx and spleen cells (DST), injected through the portal vein. Renal lab tests were collected to evaluate the onset of rejection. Survivals were evaluated as well. The end-point of the study was at onset of kidney failure or at the limit of 60 postoperative day (POD) in non-rejecting animals. Tissue samples were collected to evaluate grade and severity of rejection. RESULTS Controls died from kidney failure within 10(th) POD. Group 2 and 3, had a delayed renal graft rejection and an overall prolonged graft survival. Whole graft and spleen cells injection share this effect, while spleen administration through the portal route proved a superior effect, which is significant compared to controls (Kaplan Meier survival analysis P<0.05). CONCLUSIONS These results, from a non immunosuppressed setting, suggest that spleen plays a key role as an immunomodulatory organ.
Collapse
|
7
|
Rademacher J, Cansolino L, Lillo E, Oldani G, Delfino A, Matteotti C, Gaspari A, Maestri M, Dionigi P. [Blockade of B7:CD28 costimulatory pathway reduces the vascular damage in an experimental model of chronic rejection]. MINERVA CHIR 2005; 60:487-96. [PMID: 16402003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
AIM Costimulatory blockade and donor specific transfusion (DST) can catalyze tolerance of transplanted organs through a multistep adaptation between the recipient and donor immune systems. Such an in vivo process may prolong graft survival. Aim of this study was to evaluate the outcome of aortic transplantation under CTLA4Ig and DST in a mismatched model in rats. METHODS Orthotopic aortic transplantation was performed in recipients Lewis from Wistar-Furth rats. The animals were stratified into 3 groups, according to the postoperative treatment. Group 1 had aortic transplantation only (controls, n=6), while group 2 (n=7) had a load of donor splenocytes (DST). Group 3 was treated with DST and CTLA4Ig. All the animals were sacrificed at the 60th postoperative day and the aortic specimens were prepared for histology. Intimal cells, muscular cells and lymphocyte cell infiltration were evaluated by serial counts. RESULTS In Group 1 there was a severe chronic rejection, while group 2 showed a slower onset of chronic rejection with less inflammatory infiltrate than group 1 (P<0.05). Group 3 had the best overall outcome with lower infiltration and minimal alterations compared with groups 1 and 2. CONCLUSIONS Costimulatory blockade and DST load can prevent the onset of chronic rejection in this experimental setting. Despite the wide availability of immunosuppressors, which makes transplantation a today's clinical routine, the solution to chronic rejection is still elusive. The synergistic role of splenocytes and costimulatory blockade raises interesting perspectives about the immunomodulatory role of spleen in tolerance induction.
Collapse
Affiliation(s)
- J Rademacher
- Laboratorio di Chirurgia Sperimentale, Sezione di Chirurgia Generale, Dipartimento di Chirurgia, Università degli Studi di Pavia, Pavia
| | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Abstract
BACKGROUND There is limited information available regarding the relationship between clinical indicators of widespread disease in patients with lung cancer and the findings of transcutaneous ultrasonography. METHODS A retrospective survey was made of 279 consecutive patients with lung cancer. By reviewing the patients' records the clinical findings were divided into symptoms, signs, and laboratory tests indicative of metastatic disease. All patients had been examined by abdominal ultrasonography. RESULTS The patients included 19% with small cell carcinoma. The frequency of abdominal metastases by ultrasonography in those with small cell carcinoma was 40%, in the other patients it was 8%. Regardless of histological group, all the 40 patients with abdominal metastases by ultrasonography had at least one clinical category indicative of widespread disease and 38 (95%) had two or all three clinical categories positive. Fifty nine patients had no clinical indicators of metastases and none of these had abdominal metastases by ultrasonography. CONCLUSIONS The results of this study indicate that abdominal metastases are found in lung cancer patients with clinical findings indicative of widespread disease. No abdominal metastases were found in patients with a negative clinical evaluation. The results indicate that transcutaneous ultrasonography of the abdomen is not necessary in the initial staging if the clinical evaluation is unremarkable.
Collapse
Affiliation(s)
- P S Bakke
- Department of Thoracic Medicine, University Hospital of Haukeland, Norway
| | | | | | | | | | | |
Collapse
|
9
|
Cabrera C, Gallego C, Lopez MC, Lorenzo ML, Lillo E. Determination of levels of lead contamination in food and feed crops. J AOAC Int 1994; 77:1249-52. [PMID: 7950424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
A rapid, precise procedure is described for the determination of lead in food and feed products with electrothermal atomic absorption spectrophotometry. Samples were mineralized in a microwave acid digestion bomb in the presence of nitric acid and vanadium pentoxide. Lead concentrations were determined directly from digested samples. The detection limit was 0.04 ng/mL. Accuracy and precision were checked against National Institute of Standards and Technology standard reference material. The analytical method was tested with 51 food and feed crops from Mediterranean zones in Spain and found to be suitable for these products. Lead concentrations in samples ranged from not detectable to 2.695 micrograms/g (fresh weight).
Collapse
Affiliation(s)
- C Cabrera
- University of Granada, School of Pharmacy, Department of Nutrition and Bromatology, Spain
| | | | | | | | | |
Collapse
|
10
|
Abstract
Two hundred chronic low-back pain patients entering a functional restoration program were assessed for current and lifetime psychiatric syndromes using a structured psychiatric interview to make DSM-III-R diagnoses. Results showed that, even when the somewhat controversial category of somatoform pain disorder was excluded, 77% of patients met lifetime diagnostic criteria and 59% demonstrated current symptoms for at least one psychiatric diagnosis. The most common of these were major depression, substance abuse, and anxiety disorders. In addition, 51% met criteria for at least one personality disorder. All of the prevalence rates were significantly greater than the base rate for the general population. Finally, and most importantly, of these patients with a positive lifetime history for psychiatric syndromes, 54% of those with depression, 94% of those with substance abuse, and 95% of those with anxiety disorders had experienced these syndromes before the onset of their back pain. These are the first results to indicate that certain psychiatric syndromes appear to precede chronic low-back pain (substance abuse and anxiety disorders), whereas others (specifically, major depression) develop either before or after the onset of chronic low-back pain. Such findings substantially add to our understanding of causality and predisposition in the relationship between psychiatric disorders and chronic low-back pain. They also clearly reveal that clinicians should be aware of potentially high rates of emotional distress syndromes in chronic low-back pain and enlist mental health professionals to help maximize treatment outcomes.
Collapse
Affiliation(s)
- P B Polatin
- Department of Psychiatry, University of Texas Southwestern Medical Center
| | | | | | | | | |
Collapse
|
11
|
|
12
|
Betancourt F, Larraín F, González P, Olea E, Lillo E, Aldunate G, Danús O. [Bile duct scintigraphy in icteric syndrome of younger infants]. Rev Chil Pediatr 1983; 54:237-40. [PMID: 6686338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|